S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q4 2020

RTW Investments

Period: Q4 2020 Β· Filed: 2021-02-16
View on SEC EDGAR β†—
AUM
$5.96B
Total portfolio value
Positions
102
Reported securities
Top Holding
RCKT
15.7% $935.6M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-02-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
RCKTRocket Pharmaceuticals Inc$935.6M15.70%$54.84$3.84-93.0%
15.7%
IMVTImmunovant Inc$350.7M5.88%$46.19$38.79-16.0%
5.9%
PTCTPTC Therapeutics Inc$257.7M4.32%$61.03$83.31+36.5%
4.3%
MRTXMirati Therapeutics Inc$231.6M3.89%β€”β€”
3.9%
STOKStoke Therapeutics Inc$219.5M3.68%$61.93$32.70-47.2%
3.7%
ALNYAlnylam Pharmaceuticals Inc$218.6M3.67%$129.97$312.78+140.7%
3.7%
NTRANatera Inc$170.4M2.86%$99.52$279.32+180.7%
2.9%
DRNADicerna Pharmaceuticals Inc$159.8M2.68%β€”β€”
2.7%
ARVNArvinas Inc$152.1M2.55%$84.93$8.39-90.1%
2.5%
VCELVericel Corp$139.5M2.34%$30.88$46.98+52.1%
2.3%
AXSMAxsome Therapeutics Inc$136.3M2.29%$81.47$244.31+199.9%
2.3%
ILMNIllumina Inc$133.9M2.25%$359.92$188.68-47.6%
2.3%
CERNCerner Corp$133.6M2.24%β€”β€”
2.2%
MASIMasimo Corp$126.0M2.11%$268.38β€”
2.1%
GMEDGlobus Med Inc$107.0M1.80%$65.22$80.12+22.9%
1.8%
RNAMAvidity Biosciences Inc$102.0M1.71%β€”β€”
1.7%
TARSTarsus Pharmaceuticals Inc.$99.0M1.66%$41.33$65.44+58.3%
1.7%
AXNXAxonics Modulation Technolog$94.0M1.58%β€”β€”
1.6%
DMTKQDermTech Inc$93.7M1.57%β€”β€”
1.6%
TXG10x Genomics Inc$93.6M1.57%$141.60$39.01-72.5%
1.6%
ATHAAthira Pharma Inc$88.9M1.49%β€”β€”
1.5%
ESTAEstablishment Labs Hldgs Inc$87.3M1.46%$37.64$89.25+137.1%
1.5%
FREQFrequency Therapeutics Inc$86.8M1.46%β€”β€”
1.5%
ADVMAdverum Biotechnologies Inc$78.3M1.31%β€”β€”
1.3%
GHGuardant Health Inc$75.0M1.26%$128.88$167.98+30.3%
1.3%
LUNGPulmonx Corp$74.8M1.26%$69.02$1.39-98.0%
1.3%
PTGXProtagonist Therapeutics Inc$73.6M1.23%$20.16$131.62+552.9%
1.2%
CCCCC4 Therapeutics Inc$68.7M1.15%$33.13$4.30-87.0%
1.1%
TNDMTandem Diabetes Care Inc$63.2M1.06%$95.68$15.32-84.0%
1.1%
CLDXCelldex Therapeutics Inc New$60.0M1.01%$17.52$38.37+119.0%
1.0%

Quarter-on-Quarter Activity

Q4 2020 vs. Q3 2020

New Positions (8)

TickerIssuerNotionalSince Filing
ARVNArvinas Inc$152.1M-90.1%
GMEDGlobus Med Inc$107.0M+22.9%
TARSTarsus Pharmaceuticals Inc.$99.0M+58.3%
LUNGPulmonx Corp$74.8M-98.0%
CCCCC4 Therapeutics Inc$68.7M-87.0%
KURAKura Oncology Inc$55.6M
FPRXFive Prime Therapeutics Inc$42.8M
CRISCuris Inc$30.5M

Exited Positions (8)

TickerIssuerNotional
MYOKMyokardia Inc$127.7M
BAXBaxter International Inc$86.6M
INCYIncyte Corp$30.0M
FIXXHomology Medicines Inc$26.9M
VXRTVaxart Inc$23.4M
ADAPYAdaptimmune Therapeutics PLC$20.9M
ALTAltimmune Inc$17.6M
AMRSQAmyris Inc$15.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ILMNIllumina Inc$79.8M+106.7%-47.6%
FULCFulcrum Therapeutics Inc$15.1M+80.0%
OMOutset Med Inc$13.0M+44.5%
GHGuardant Health Inc$22.5M+24.0%+30.3%
BLUBellus Health Inc New$6.2M+23.7%
CERNCerner Corp$32.9M+22.2%
ITOSIteos Therapeutics Inc$15.1M+19.0%
VCELVericel Corp$68.2M+17.3%+52.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”
OSUROraSure Technologies Inc$-23.3M-91.1%
BIORProgenity Inc$-1.9M-63.6%
ITMRItamar Med Ltd$-4.8M-50.0%
INMDInmode Ltd$-3.1M-50.0%
PROFProfound Med Corp$-1.8M-50.0%
PSNLPersonalis Inc$-0.9M-50.0%
TBIOTranslate Bio Inc$3.9M-20.5%
NSTGQNanoString Technologies Inc$11.4M-15.1%
← Back to Hedge Funds